Moa Life Plus

Moa Life Plus FCF per Share

The Free Cash Flow per Share of Moa Life Plus (142760.KQ) as of Oct 30, 2026 is -387.42 KRW. In the previous year, Free Cash Flow per Share was -97.46 KRW — a change of 297.53% (lower).

FCF per Share

-387.42KRW

YoY

297.53%

Last updated:

Free Cash Flow per Share of Moa Life Plus is 2025 -387.42 KRW. Free Cash Flow per Share of Moa Life Plus was 2024 -97.46 KRW. It decreases by 297.53% lower compared to the previous year.

The Moa Life Plus FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-803.93 KRW
Jan 1, 2019
-1,610.08 KRW
Jan 1, 2020
-1,454.14 KRW
Jan 1, 2021
-426.24 KRW
Jan 1, 2022
-1,398.42 KRW
Jan 1, 2023
363.17 KRW
Jan 1, 2024
-97.46 KRW
Jan 1, 2025
-387.42 KRW
The Moa Life Plus FCF per Share history
YEARFCF per ShareYoY
-387.42KRW+297.53%
-97.46KRW-126.83%
363.17KRW-125.97%
-1,398.42KRW+228.08%
-426.24KRW-70.69%
-1,454.14KRW-9.69%
-1,610.08KRW+100.28%
-803.93KRW+15.45%
-696.36KRW+21.69%
-572.26KRW+75.54%
-325.99KRW-52.00%
-679.16KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Moa Life Plus Stock analysis

What does Moa Life Plus do? BL Corp. develops biopharmaceutical products and manufactures health functional foods and functional cosmetics. The company distributes Glu 100 Tablets, CellribonQ, and GentaQ to general hospitals and pharmacies. It generates revenue through the sale of these pharmaceuticals and health-related products to healthcare providers and retail outlets. The firm's product portfolio includes Glu 100 Tablets, CellribonQ, and GentaQ, which are distributed to general hospitals and pharmacies. These products are sold as part of the company's pharmaceutical and medical supplies distribution business. Revenue is derived from the sale of these branded medicines and health functional products. BL Corp. focuses on the distribution of specific branded pharmaceuticals and health functional products. The company's primary customers are general hospitals and pharmacies, which purchase Glu 100 Tablets, CellribonQ, and GentaQ for resale or direct use in healthcare settings. Moa Life Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moa Life Plus stock

Free Cash Flow per Share of Moa Life Plus is -387.42 KRW in 2025.

Free Cash Flow per Share of Moa Life Plus changed from -97.46 KRW to -387.42 KRW, representing a 297.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Moa Life Plus since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Moa Life Plus

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Moa Life Plus